Oruka Therapeutics, Inc. ORKA Current Liabilities Assumed in Business Combination

Current Liabilities Assumed in Business Combination at other companies

CG OncologyCGON

$307K—

Zeta Global HoldingsZETA

$47.88M+247%

Construction PartnersROAD

$0—

Zeta Global HoldingsZETA

$22.3M-5.7%

Intuitive Machines, Inc.LUNR

$874.75K—

PenumbraPEN

$211.73M+33.5%

Other financials

Income statement

See full

Revenue-—

Operating income-$36.4M-45.2%

Net income-$31.8M-51.5%

EPS (diluted)-$0.46+93.4%

Balance sheet

See full

Cash & equivalents$49.5M-40.7%

Total debt$1.8M+90.8%

Total equity$486.7M+33.4%

Total assets$504.5M+33.8%

Cash flow

See full

Operating cash flow-$23.6M-13.0%

CapEx$73.0K+462%

Free cash flow-$23.7M-13.3%

Valuation

See full

Market cap$5.03B+533%

Returns & leverage

See full

Return on equity-27.3%-11.1pp

Debt / equity0×0.0×

Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities.

The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s current liabilities assumed in business combination.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s current liabilities assumed in business combination?: Oruka Therapeutics, Inc. (ORKA) reported current liabilities assumed in business combination of $54K in Q3 2024.
What does current liabilities assumed in business combination mean?: This represents the current obligations and liabilities taken on by the company as a result of a business combination or acquisition. Monitoring this figure is essential for assessing the short-term debt burden and operational commitments inherited from acquired entities.